Danaher Reports Second Quarter 2021 Results

WASHINGTON, July 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the second quarter 2021.  All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended July 2, 2021, net earnings were $1.7 billion, or $2.28 per diluted common share which represents an 84.0% year-over-year... Read more

Bruker Announces Date and Time of Second Quarter 2021 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2021 financial results on Monday, August 2, 2021, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can... Read more

Brooks Automation Announces Fiscal 2021 Third Quarter Earnings Conference Call and Webcast

Brooks Automation Announces Fiscal 2021 Third Quarter Earnings Conference Call and Webcast CHELMSFORD, Mass., July 20, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 third quarter which ended on June 30, 2021 on Thursday, August 5, 2021 after the market closes. The Company will host a conference call and live webcast to... Read more

Pacific Biosciences of California, Inc. Second Quarter 2021 Financial Results Call

MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its second quarter 2021 financial results on Tuesday, August 3, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/. Date:... Read more

Xylem Announces Earnings Call Time Change: Second Quarter 2021 Earnings Call To Occur On August 3, 2021 At 11 a.m. EDT

RYE BROOK, N.Y.–(BUSINESS WIRE)–Jul. 15, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today announced an update to the timing of its previously announced second quarter earnings conference call. The Company will release its second quarter 2021 results at 6:55 a.m. (EDT) on... Read more

Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the second quarter 2021 following the close of market on Thursday, August 5, 2021. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Chief Financial Officer, will host... Read more

Xylem To Release Second Quarter 2021 Financial Results On August 3, 2021

RYE BROOK, N.Y.–(BUSINESS WIRE)–Jul. 13, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its second quarter 2021 results at 6:55 a.m. (ET) on Tuesday, August 3, 2021. At 10:00 a.m. (ET), Xylem’s senior management team will host a conference call with... Read more

Thermo Fisher Scientific To Showcase Investments and Innovation at DCAT Week 2021

Thermo Fisher Scientific To Showcase Investments and Innovation at DCAT Week 2021 Strategic investments over the last two years expand global capabilities to support advanced therapies and large molecule development and manufacturing WALTHAM, Mass., July 12, 2021 /PRNewswire/ — This week, Thermo Fisher Scientific will highlight its investments and innovations over the past 12 months across its... Read more

Roche’s Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children

The authorisation enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalised adult and paediatric patients Basel, 25 June 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19... Read more